Abstract:Background Anthracyclines including doxorubicin are essential components of many cancer chemotherapy regimens, but their cardiotoxicity severely limits their use. New strategies for treating anthracycline-induced cardiotoxicity (AIC) are still needed. Anthracycline-induced DNA double-strand break (DSB) is the major cause of its cardiotoxicity. However, DSB-based drug screening for AIC has not been performed possibly due to the limited throughput of common assays for detecting DSB. To discover new therapeutic candidates for AIC, here we established a method to rapidly visualize and accurately evaluate the intranuclear anthracycline-induced DSB, and performed a screening for DSB inhibitors. Results First, we constructed a cardiomyocyte cell line stably expressing EGFP-53BP1, in which the formation of EGFP-53BP1 foci faithfully marked the doxorubicin-induced DSB, providing a faster and visible approach to detecting DSB. To quantify the DSB, we used a deep learning-based image analysis method, which showed the better ability to distinguish different cell populations undergoing different treatments of doxorubicin or reference compounds, compared with the traditional threshold-based method. Subsequently, we applied the deep learning-assisted high-content screening method to 315 compounds and found three compounds (kaempferol, kaempferide, and isoliquiritigenin) that exert cardioprotective effects in vitro. Among them, the protective effect of isoliquiritigenin is accompanied by the up-regulation of HO-1, down-regulation of peroxynitrite and topo II, and the alleviation of doxorubicin-induced DSB and apoptosis. The results of animal experiments also showed that isoliquiritigenin maintained the myocardial tissue structure and cardiac function in vivo. Moreover, isoliquiritigenin did not affect the killing of HeLa and MDA-MB-436 cancer cells by doxorubicin and thus has the potential to be a lead compound to exert cardioprotective effects without affecting the antitumor effect of doxorubicin. Conclusions Our findings provided a new method for the drug discovery for AIC, which combines phenotypic screening with artificial intelligence. The results suggested that isoliquiritigenin as an inhibitor of DSB may be a promising drug candidate for AIC.

In vitro study on Anthracycline-induced injury of cardiomyocyte H9c2

Deep Learning-Assisted High-Content Screening Identifies Isoliquiritigenin As an Inhibitor of DNA Double-Strand Breaks for Preventing Doxorubicin-Induced Cardiotoxicity

Astragalus membranaceus prevents daunorubicin-induced apoptosis of cultured neonatal cardiomyocytes: role of free radical effect of Astragalus membranaceus on daunorubicin cardiotoxicity.

Protective Effect of Two Alkaloids from Hippophae rhamnoides Linn. against Doxorubicin-Induced Toxicity in H9c2 Cardiomyoblasts

Effects of L- carnitine on apoptosis in cultured neonatal rat cardiomyocytes induced by hypoxia/reoxygenation

Modulation of caveolins, integrins and plasma membrane repair proteins in anthracycline-induced heart failure in rabbits

An in vivo and in vitro model on the protective effect of corilagin on doxorubicin‐induced cardiotoxicity via regulation of apoptosis and PI3‐K/AKT signaling pathways

Protective Effects of L-carnitine Against Simulated Ischemia and Reperfusion Injury in Cultured Neonatal Rat Cardiomyocytes

Matrine attenuating cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity through improved mitochondrial membrane potential and activation of mitochondrial respiratory chain Complex I pathway

Effects of Astragalus membranaceus and its combination with daunorubicin on the proliferation of NB4 cell line

Effect of L-carnitine on Apoptosis and Oxidant Damage of Cardiomyocytes Induced by Hypoxia/reoxygenation in Vitro

Protective Effect of Long Noncoding RNA OXCT1-AS1 on Doxorubicin-Induced Apoptosis of Human Myocardial Cells by the Competitive Endogenous RNA Pattern

[Study on Protective Effects of Panax Notoginseng Saponins on Doxorubicin-Induced Myocardial Damage].

Effect of Gilal Growth Factor on Toxic Cardiomyocytes by Adriamycin

Assessment of Subclinical Doxorubicin-induced Cardiotoxicity in a Rat Model by Speckle-Tracking Imaging

Protective Effect of Lycopene on Hypoxia/Reoxygenation Injury in Rat Cardiomyocytes and Its Mechanism

Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells

Pro-Apoptotic Role Of Nuclear Factor-Kappa B In Adriamycin-Induced Acute Myocardial Injury In Rats

Isorhamnetin Protects Against Doxorubicin-Induced Cardiotoxicity in Vivo and in Vitro

Abstract 18141: 3-Dimensional Light-Sheet Fluorescent Microscopy and High-Frequency Ultrasonic Transducers to Characterize Doxorubicin-Induced Cardiac Injury and Regeneration